AU2003222667A1 - 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases - Google Patents
1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseasesInfo
- Publication number
- AU2003222667A1 AU2003222667A1 AU2003222667A AU2003222667A AU2003222667A1 AU 2003222667 A1 AU2003222667 A1 AU 2003222667A1 AU 2003222667 A AU2003222667 A AU 2003222667A AU 2003222667 A AU2003222667 A AU 2003222667A AU 2003222667 A1 AU2003222667 A1 AU 2003222667A1
- Authority
- AU
- Australia
- Prior art keywords
- thiazoles
- treatment
- cardiovascular diseases
- lxr modulators
- lxr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37465102P | 2002-04-23 | 2002-04-23 | |
| US60/374,651 | 2002-04-23 | ||
| PCT/US2003/012250 WO2003090746A1 (en) | 2002-04-23 | 2003-04-21 | 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003222667A1 true AU2003222667A1 (en) | 2003-11-10 |
Family
ID=29270536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003222667A Abandoned AU2003222667A1 (en) | 2002-04-23 | 2003-04-21 | 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003222667A1 (en) |
| WO (1) | WO2003090746A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005009811D1 (en) | 2004-03-26 | 2008-10-30 | Hoffmann La Roche | TETRAHYDROCARBAZOLE AND DERIVATIVES |
| FR2869904B1 (en) | 2004-05-07 | 2006-07-28 | Fournier S A Sa Lab | MODULATORS OF LXR RECEIVERS |
| CA2811145A1 (en) | 2010-09-07 | 2012-03-15 | Snu R&Db Foundation | Sesterterpene compound and use thereof |
| EP3091970B1 (en) | 2014-01-10 | 2020-10-28 | Rgenix, Inc. | Lxr agonists and uses thereof |
| JP7025022B2 (en) | 2016-01-11 | 2022-02-24 | ザ ロックフェラー ユニバーシティー | Methods for the treatment of myeloid-derived inhibitory cell-related disorders |
| US20190275012A9 (en) * | 2016-07-29 | 2019-09-12 | Lupin Limited | Substituted thiazolo-pyridine compounds as malt1 inhibitors |
| EP3713575A4 (en) | 2017-11-21 | 2021-08-25 | Rgenix, Inc. | Polymorphs and uses thereof |
| HUE067466T2 (en) | 2019-12-13 | 2024-10-28 | Inspirna Inc | Metal salts and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0201033A3 (en) * | 1999-05-17 | 2003-03-28 | Novo Nordisk As | Glucagon antagonists/inverse agonists, process for their preparation and their use |
| JP4155351B2 (en) * | 2001-02-20 | 2008-09-24 | 中外製薬株式会社 | Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic regulators |
| US6924311B2 (en) * | 2001-10-17 | 2005-08-02 | X-Ceptor Therapeutics, Inc. | Methods for affecting various diseases utilizing LXR compounds |
-
2003
- 2003-04-21 AU AU2003222667A patent/AU2003222667A1/en not_active Abandoned
- 2003-04-21 WO PCT/US2003/012250 patent/WO2003090746A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003090746A1 (en) | 2003-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003212323A1 (en) | Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases | |
| WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2003279819A1 (en) | Shrimp and the production thereof | |
| HK1098737A1 (en) | Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane | |
| AU2003238011A1 (en) | Treating vitamin d responsive diseases | |
| AU2003290415A1 (en) | Herbal oro-dental care composition and process for preparing the same | |
| AU2003212634A1 (en) | Compounds useful in the treatment of cancer | |
| AU2003211453A1 (en) | External compositions for the skin | |
| AU2003258145A1 (en) | Substituted phenylindoles for the treatment of hiv | |
| AU2003220521A1 (en) | Methods of treatment with lxr modulators | |
| AU2003272317A1 (en) | Treatment of periodontal disease with photosensitizers | |
| AU2003223684A1 (en) | Lxr modulators for the treatment of cardiovascular diseases | |
| AU2003276129A1 (en) | Compositions and methods for darkening the skin | |
| AU2003903242A0 (en) | Process for the treatment of wood | |
| AU2003254146A1 (en) | Methods for the treatment of parkinson's disease | |
| AU2003222667A1 (en) | 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases | |
| AU2003238046A1 (en) | Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer's disease | |
| AU2002224839A1 (en) | Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases | |
| AU2003219511A1 (en) | Carnitine in the treatment of geriatric depression | |
| AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
| EG24959A (en) | Indoles useful in the treatment of androgenreceptor related diseases. | |
| WO2004105780A3 (en) | Compositions comprising gastrin compounds and their use in diabetes | |
| AU2003240174A1 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
| AU2002952537A0 (en) | The production of fodder | |
| AU2003240169A1 (en) | Dermocosmetic treatment by metabolic phospholipids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |